This list is based on the watchlists of people on Stock Events who follow ERNA.BOATS. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Show more...
FAQ
What is Ernexa Therapeutics stock price today?▼
The current price of ERNA.BOATS is $11.46 USD — it has increased by +5.04% in the past 24 hours. Watch Ernexa Therapeutics stock price performance more closely on the chart.
What is Ernexa Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ernexa Therapeutics stocks are traded under the ticker ERNA.BOATS.
When is the next Ernexa Therapeutics earnings date?▼
Ernexa Therapeutics is going to release the next earnings report on August 17, 2026.
In which sector is Ernexa Therapeutics located?▼
Ernexa Therapeutics operates in the Other sector.
When did Ernexa Therapeutics complete a stock split?▼
The last stock split for Ernexa Therapeutics was on May 04, 2026 with a ratio of 1:25.